NewslettersHematopoiesis NewsFDA Grants Accelerated Approval to Asciminib for Adult Patients With Newly Diagnosed Ph+ CML-CPBy lbeveridge - November 1, 20240336The FDA granted an accelerated approval to asciminib for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.[Pharmacy Times]Press Release